Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers​", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Dueland S, Smedman TM, Syversveen T, Khan A, Grut H, Line PD(2026) Liver Transplantation for Nonresectable Colorectal Liver Metastases: Ten-year Follow-up and Assessment of Curative Rate in the SECA-II Study Ann Surg(in press) DOI 10.1097/SLA.0000000000007200, PubMed 42572136
Erdal MS, Qi J, Erusappan PM, Schubert M, Koser F, Basson A, Fischer K, Dzekhtsiarova Y, Mehnert C, Poetsch M, Fomin A, Hou Y, Laasmaa M, Ugland HK, Lunde IG, Gautel M, Longman C, Jungbluth H, Sundnes J, Linke WA, Guan K, Louch WE, Li J(2026) Biallelic titin truncation disrupts sarcomere assembly and function in patient-derived iPSC-cardiomyocytes J Mol Cell Cardiol(in press) DOI 10.1016/j.yjmcc.2026.08.001, PubMed 42570788
Mostad P, Egeland T, Vigeland MD(2026) Unattainable regions in the space of genetic relationships J Math Biol, 93(3) DOI 10.1007/s00285-026-02452-9, PubMed 42562941